View Article

  • Implants For Cardiovascular Diseases

  • 1Student of Six Sigma Institute of Technology and Science
    2Principal of Six Sigma Institute of Technology and Science
    3Asst. Professor Six Sigma Institute of Technology and Science
     

Abstract

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality globally, necessitating continuous advancements in medical interventions. Implantable devices have emerged as promising solutions for managing various aspects of cardiovascular pathologies. This comprehensive review explores the current landscape of innovative implants in the realm of cardiovascular diseases. The review begins by examining the pivotal role of implantable devices in addressing cardiac conditions, ranging from heart failure to arrhythmias. Focus is placed on cardiac rhythm management devices, including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy devices, highlighting their evolving technologies and clinical applications. Furthermore, the review delves into advancements in the field of cardiovascular stents, discussing novel materials and designs aimed at optimizing vascular patency while minimizing complications. The integration of drug-eluting technologies and bioresorbable materials into stent development is explored, with emphasis on their impact on patient outcomes. The discussion extends to ventricular assist devices (VADs) and total artificial hearts, elucidating their role in providing temporary or long-term mechanical circulatory support. A critical evaluation of challenges and future prospects in enhancing the biocompatibility and durability of these devices is presented. In addition, the review encompasses the burgeoning field of bioelectronic implants, elucidating how neuromodulation devices and bioelectronic medicine are revolutionizing the management of hypertension and heart failure. The integration of smart sensors and closed-loop systems for real-time monitoring and adaptive interventions is discussed in the context of personalized cardiovascular care. Ultimately, this review aims to provide a comprehensive overview of the diverse landscape of cardiovascular implants, offering sights into their evolving technologies, clinical efficacy, and potential avenues for future research and development.The continuous innovation in implantable devices holds great promise for improving the prognosis and quality of life for individuals affected by cardiovascular diseases.

Keywords

Cardiovascular disease, Implants

Reference

  1. Tetali, S., Fricker, A., Van Dom burg, Y., & Roy, I. (2023). Intelligent biomaterials for cardiovascular applications. Current Opinion in Biomedical Engineering, 28, 100474. https://doi.org/10.1016/j.cobme.2023.100474
  2. Qi, P., Maitz, M. F., & Huang, N. (2013). Surface modification of cardiovascular materials and implants. Surface and Coatings Technology, 233, 80–90. Doi: 10.1016/j.surfcoat.2013.02.00
  3. Adhami M, Martin NK, Maguire C, Courtenay AJ, Donnelly RF, Domínguez-Robles J, Larrañeta E. Drug loaded implantable devices to treat cardiovascular disease. Expert Opin Drug Deliv. 2023 Apr;20(4):507-522. Doi: 10.1080/17425247.2023.2190580.
  4. Nangia, R., Singh, H., & Kaur, K. (2016). Prevalence of cardiovascular disease (CVD) risk factors. Medical Journal Armed Forces India, 72(4), 315–319. Doi: 10.1016/j.mjafi.2014.07.007  
  5. Bussooa, A., Neale, S., & Mercer, J. (2018). Future of Smart Cardiovascular Implants. Sensors, 18(7), 2008. doi:10.3390/s18072008
  6. Jung, F., Wischke, C., & Lendlein, A. (2010). Degradable, Multifunctional Cardiovascular Implants: Challenges and Hurdles. MRS Bulletin, 35(08), 607–613. doi:10.1557/mrs2010.529 
  7. Levy, R. J., Johnston, T. P., Sintov, A., & Golomb, G. (1990). Controlled release implants for cardiovascular disease. Journal of Controlled Release, 11(1-3), 245–254. doi:10.1016/0168-3659(90)90137-i
  8. Wischke, C., & Lendlein, A. (2011). Designing multifunctional polymers for cardiovascular implants. Clinical Hemorheology and Microcirculation, 49(1-4), 347–355. doi:10.3233/ch-2011-1485 
  9. Stanis?awska, A... "Biomaterials and Implants in Cardiac and Vascular Surgery - Review" Advances in Materials Science, vol.14, no.3, 2014, pp.5-17. https://doi.org/10.2478/adms-2014-0010
  10. Hermawan, H., Dubé, D., & Mantovani, D. (2010). Degradable metallic biomaterials for cardiovascular applications. Metals for Biomedical Devices, 379–404. doi:10.1533/9781845699246.4.379
  11. Lei, L., Guo, S.-R., Chen, W.-L., Rong, H.-J., & Lu, F. (2011). Stents as a platform for drug delivery. Expert Opinion on Drug Delivery, 8(6), 813–831. doi:10.1517/17425247.2011.572068
  12. Mani, G. (2013). Stent-based drug-delivery systems: current challenges and future trends. Therapeutic Delivery, 4(9), 1079–1082. doi:10.4155/tde.13.63
  13. Merchant, Faisal M., G. William Dec, and Jagmeet P. Singh. "Implantable sensors for heart failure." Circulation: Arrhythmia and Electrophysiology 3, no. 6 (2010): 657-667.
  14. Implantable cardioverter-defibrillators (ICDs) - Mayo Clinic
  15. Implantable Cardioverter Defibrillator (ICD) - Dr Matthew Ginks (oxfordheartdoctor.com)
  16. Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., … Pehrson, S. (2016). Defibrillator Implantation in Patients with Nonischaemic Systolic Heart Failure. New England Journal of Medicine, 375(13), 1221–1230. doi:10.1056/nejmoa1608029  
  17. A. Molloy et al., "Challenges to the Development of the Next Generation of Self-Reporting Cardiovascular Implantable Medical Devices," in IEEE Reviews in Biomedical Engineering, vol. 15, pp. 260-272, 2022, doi: 10.1109/RBME.2021.3110084
  18. Lee, Justin Z., Siva K. Mulpuru, and Win K. Shen. "Leadless pacemaker: performance and complications." Trends in Cardiovascular Medicine 28, no. 2 (2018): 130-141.
  19. Khan, K., Kim, J. A., Gurgu, A., Khawaja, M., Cozma, D., & Chelu, M. G. (2021). Innovations in Cardiac Implantable Electronic Devices. Cardiovascular Drugs and Therapy. doi:10.1007/s10557-021-07163-5 
  20. Sengel, Ceyda Tuba. "Delivery of nanoparticles for the treatment of cardiovascular diseases." Global Journal of Obesity, Diabetes and Metabolic Syndrome 2 (2015): 18-21.
  21. Abraham, William T., and Leor Perl. "Implantable hemodynamic monitoring for heart failure patients." Journal of the American College of Cardiology 70, no. 3 (2017): 389-398.

 

Photo
Komal Bisht
Corresponding author

Student of Six Sigma Institute of Technology and Science

Photo
Vijay Singh
Co-author

Principal of Six Sigma Institute of Technology and Science

Photo
Sushmita Bala
Co-author

Asst. Professor Six Sigma Institute of Technology and Science

Komal Bisht*, Vijay Singh, Sushmita Bala, Implants For Cardiovascular Diseases, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 12, 650-658. https://doi.org/10.5281/zenodo.10428745

More related articles
Role Of Aprepitant in The Management of Chemothera...
Madhumanchi Prathyusha , Koyyaguri Usha Kiranmai , Muppidi Manogn...
Development And Evaluation of Microsphere Loaded M...
Vishal Edake, K. R. Biyani, R. R. Pagore, Dr. Mohd Hasib Ahmed...
Data Integrity in the Pharmaceutical Industry: ALC...
Omkar Fule, Sanika Gavade , Keshav Pawar , Dr. Rajendra Patil ,...
Development and Evaluation of Tapentadol Nanospheres by using Solvent Evaporatio...
Anurag Dwivedi, Mohammad Sarfraz, Sandeep Pandey, Sagar Bansal...
Regulatory Framework for Herbal Medical Products: Laws, Regulations, and Complia...
Dhanashree Dorge, Vaijayanti kakade, Trupti Golande, Dr. J. B. kandale...
Related Articles
Gene Therapy For Oral And Periodontal Diseases: A Review Of Recent Advances...
Niraj Chorbele , Dr. Vishal Pande, Dr. Prashant Patil...
Formualtion & Evaluation of Itraconazole Controlled Release Tablet...
Vaishnavi Jagtap, Dr. Manisha Kitukale, Rushikesh Wanole, Sanubar Taihsin Khan, Vaishanvi Yadav, Shu...
Role Of Aprepitant in The Management of Chemotherapy - Induced Nausea and Vomiti...
Madhumanchi Prathyusha , Koyyaguri Usha Kiranmai , Muppidi Manogna , Dr. Sk. Shakeela...
More related articles
Role Of Aprepitant in The Management of Chemotherapy - Induced Nausea and Vomiti...
Madhumanchi Prathyusha , Koyyaguri Usha Kiranmai , Muppidi Manogna , Dr. Sk. Shakeela...
Development And Evaluation of Microsphere Loaded Mucoadhesive Gel...
Vishal Edake, K. R. Biyani, R. R. Pagore, Dr. Mohd Hasib Ahmed...
Data Integrity in the Pharmaceutical Industry: ALCOA+ Principles and Regulatory ...
Omkar Fule, Sanika Gavade , Keshav Pawar , Dr. Rajendra Patil , Dr. Swati Burungale ...
Role Of Aprepitant in The Management of Chemotherapy - Induced Nausea and Vomiti...
Madhumanchi Prathyusha , Koyyaguri Usha Kiranmai , Muppidi Manogna , Dr. Sk. Shakeela...
Development And Evaluation of Microsphere Loaded Mucoadhesive Gel...
Vishal Edake, K. R. Biyani, R. R. Pagore, Dr. Mohd Hasib Ahmed...
Data Integrity in the Pharmaceutical Industry: ALCOA+ Principles and Regulatory ...
Omkar Fule, Sanika Gavade , Keshav Pawar , Dr. Rajendra Patil , Dr. Swati Burungale ...